Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with short ...
Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Audi's smallest crossover, the Q3, might also be its most important. The Q3 arrived in the United States in 2015, and the current second generation debuted in 2019 riding on a new platform with ...
In the realm of first-world problems, your cheap wall clock doesn’t keep time, so you have to keep setting it. The answer? Of course, you connect it to NTP and synchronize the clock with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results